Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty
Total hip and knee arthroplasty are common major orthopedic operations being performed on an increasing number of patients. Many patients undergoing total joint arthroplasty (TJA) are on chronic antithrombotic agents due to other medical conditions, such as atrial fibrillation or acute coronary synd...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-02-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1010-660X/57/2/188 |
| _version_ | 1797710381592870912 |
|---|---|
| author | Daniel C. Santana Matthew J. Hadad Ahmed Emara Alison K. Klika Wael Barsoum Robert M. Molloy Viktor E. Krebs Michael R. Bloomfield Nicolas S. Piuzzi |
| author_facet | Daniel C. Santana Matthew J. Hadad Ahmed Emara Alison K. Klika Wael Barsoum Robert M. Molloy Viktor E. Krebs Michael R. Bloomfield Nicolas S. Piuzzi |
| author_sort | Daniel C. Santana |
| collection | DOAJ |
| description | Total hip and knee arthroplasty are common major orthopedic operations being performed on an increasing number of patients. Many patients undergoing total joint arthroplasty (TJA) are on chronic antithrombotic agents due to other medical conditions, such as atrial fibrillation or acute coronary syndrome. Given the risk of bleeding associated with TJAs, as well as the risk of thromboembolic events in the post-operative period, the management of chronic antithrombotic agents perioperatively is critical to achieving successful outcomes in arthroplasty. In this review, we provide a concise overview of society guidelines regarding the perioperative management of chronic antithrombotic agents in the setting of elective TJAs and summarize the recent literature that may inform future guidelines. Ultimately, antithrombotic regimen management should be patient-specific, in consultation with cardiology, internal medicine, hematology, and other physicians who play an essential role in perioperative care. |
| first_indexed | 2024-03-12T06:51:22Z |
| format | Article |
| id | doaj.art-8ca1adbf61ec40b082757e2ffc1bc472 |
| institution | Directory Open Access Journal |
| issn | 1010-660X |
| language | English |
| last_indexed | 2024-03-12T06:51:22Z |
| publishDate | 2021-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-8ca1adbf61ec40b082757e2ffc1bc4722023-09-03T00:16:10ZengMDPI AGMedicina1010-660X2021-02-015718818810.3390/medicina57020188Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee ArthroplastyDaniel C. Santana0Matthew J. Hadad1Ahmed Emara2Alison K. Klika3Wael Barsoum4Robert M. Molloy5Viktor E. Krebs6Michael R. Bloomfield7Nicolas S. Piuzzi8Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH 44195, USADepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH 44195, USADepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH 44195, USADepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH 44195, USAHealthcare Outcomes Performance Company (HOPCo), Phoenix, AZ 85023, USADepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH 44195, USADepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH 44195, USADepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH 44195, USADepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH 44195, USATotal hip and knee arthroplasty are common major orthopedic operations being performed on an increasing number of patients. Many patients undergoing total joint arthroplasty (TJA) are on chronic antithrombotic agents due to other medical conditions, such as atrial fibrillation or acute coronary syndrome. Given the risk of bleeding associated with TJAs, as well as the risk of thromboembolic events in the post-operative period, the management of chronic antithrombotic agents perioperatively is critical to achieving successful outcomes in arthroplasty. In this review, we provide a concise overview of society guidelines regarding the perioperative management of chronic antithrombotic agents in the setting of elective TJAs and summarize the recent literature that may inform future guidelines. Ultimately, antithrombotic regimen management should be patient-specific, in consultation with cardiology, internal medicine, hematology, and other physicians who play an essential role in perioperative care.https://www.mdpi.com/1010-660X/57/2/188arthroplastyanticoagulationvenous thromboembolismmajor bleedingsurgical complications |
| spellingShingle | Daniel C. Santana Matthew J. Hadad Ahmed Emara Alison K. Klika Wael Barsoum Robert M. Molloy Viktor E. Krebs Michael R. Bloomfield Nicolas S. Piuzzi Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty Medicina arthroplasty anticoagulation venous thromboembolism major bleeding surgical complications |
| title | Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty |
| title_full | Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty |
| title_fullStr | Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty |
| title_full_unstemmed | Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty |
| title_short | Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty |
| title_sort | perioperative management of chronic antithrombotic agents in elective hip and knee arthroplasty |
| topic | arthroplasty anticoagulation venous thromboembolism major bleeding surgical complications |
| url | https://www.mdpi.com/1010-660X/57/2/188 |
| work_keys_str_mv | AT danielcsantana perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty AT matthewjhadad perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty AT ahmedemara perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty AT alisonkklika perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty AT waelbarsoum perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty AT robertmmolloy perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty AT viktorekrebs perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty AT michaelrbloomfield perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty AT nicolasspiuzzi perioperativemanagementofchronicantithromboticagentsinelectivehipandkneearthroplasty |